Company

Company. We are committed to bring advances in the Genomics arena to everyday’s health care and disease prevention.

Technology. Our technology solves DNA sequencing critical limitations allowing simultaneous genome and epigenome analysis.

Products: Aniling products are based on GEUS technology and provide a bolt-on workflow from library preparation to clinical report.

About Us

GEUS Technology

Aniling owns the GEUS technology, which unifies genetic and epigenetic sequencing and provides end-to-end solutions for the right treatment decisions in oncology. Based on GEUS, Aniling is developing a set of products for cancer diagnostic.

GEUS-CLL

The first Aniling product is the most comprehensive Chronic Lymphocytic Leukemia Next Generation Sequencing diagnostics panel. The GEUS-CLL delivers accurate staging and treatment decisions. Aniling S.L. provides the GEUS-CLL diagnostic test as a service to other laboratories and hospitals.

Latest News

News

Aniling at the DxPx conference in Munich

Aniling is attending the DxPx conference in Munich! Our experience at this event, including one-to-one meetings, has provided us with a great opportunity to connect with industry leaders and investors …

Read Our Blog

Get in touch